The European Medicines Agency (EMA) has certified the Biocon drug product and substance facilities in the city's southern suburb for good manufacturing practice.

"We have received a certificate from EMA for the good manufacturing practice compliance by our biological drug product and substance facilities at Bengaluru," said the city-based leading biotech firm in a statement on Saturday.

In March, the European regulator (EMA) inspected the twin facilities where a range of bio-similars are manufactured. "It was a surveillance inspection of our facilities and a pre-approval inspection of our additional manufacturing line," said the statement.

Also Read- Greenland Lost More than 2 Billion Tons of Ice, with over 40% of Country Experiencing Unusual Melting

The international certification would enable the company to address the patients' needs in the European Union (EU) markets and enhance access to its bio-similars, said a Biocon's spokesperson in the statement. (IANS)